ReviewCancers2025
Efficiency of Fulvestrant Monotherapy After CDK4/6 Inhibitor Exposure: Is This a Viable Choice?
Nanae Ogata et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ReviewCancers2025
Nanae Ogata et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.